MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ehf2.15145

Медицинская библиотека · ESC heart failure · 2024

Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats.

Nordén Einar Sjaastad, Bendiksen Bård Andre, Bergo Kaja Knudsen, Espe Emil Knut Stenersen, McGinley Gary, Hasic Almira, Hauge-Iversen Ida Marie, Ugland Hege Katrin, Shen Xin, Frisk Michael, Mabotuwana Nishani S, Louch William E, Hussain Rizwan I, Zhang Lili, Sjaastad Ivar, Cataliotti Alessandro, Christensen Geir

СтатьяПеревод в очереди

Аннотация

AIMS: Sacubitril/valsartan (Sac/Val) is used for treatment of heart failure. The effect of Sac/Val on regional dysfunction following myocardial infarction (MI) remains uncertain. This study aimed at understanding the effects of Sac/Val on regional function after MI.

METHODS AND

RESULTS

MI or sham surgery was performed in Sprague-Dawley rats. Animals were randomized to treatment with Sac/Val, valsartan (Val) or vehicle (Veh). Magnetic resonance imaging was used to acquire left ventricular volumes and strain. Left ventricular tissue was obtained for wesern blotting, PCR and Masson's trichrome staining. Isolated cardiac fibroblasts were cultured with Veh, atrial natriuretic peptide (ANP), adrenomedullin (ADM) and sacubitrilat, and collagen expression assessed with droplet digital PCR.

RESULTS

Sac/Val reduced ventricular end-diastolic volume by 18% compared with Veh, and preserved circumferential systolic strain in the zone proximal to infarction compared with sham after 42 days of treatment (peak strain ± SEM: sham: -0.19 ± 0.01%; Sac/Val: -0.14 ± 0.02%; Val: -0.10 ± 0.02%; Veh: -0.10 ± 0.02%). Masson's trichrome staining demonstrated lower fibrotic deposition in the intermediate zone with Sac/Val treatment than Veh (sham: 2.29 ± 0.17%; Sac/Val: 2.31 ± 0.27%; Val: 3.22 ± 0.60%; Veh: 4.14 ± 0.48%). The amounts of the pro-apoptotic caspase 3 cleavage fragments p19/17 were 89% higher in Val than sham, with Sac/Val showing no significant increase compared with sham. Collagen expression in human fibroblast culture was lower in cells co-treated with sacubitrilat and ANP, an effect not observed with sacubitrilat/ADM co-treatment.

CONCLUSIONS

Sac/Val preserves in vivo myocardial function in the region most proximal to MI in rats and reduces left ventricular dilatation. These effects may be related to a reduction in both fibrosis and pro-apoptotic signalling.

Для цитирования: Nordén Einar Sjaastad, Bendiksen Bård Andre, Bergo Kaja Knudsen, Espe Emil Knut Stenersen, McGinley Gary, Hasic Almira, Hauge-Iversen Ida Marie, Ugland Hege Katrin, Shen Xin, Frisk Michael, Mabotuwana Nishani S, Louch William E, Hussain Rizwan I, Zhang Lili, Sjaastad Ivar, Cataliotti Alessandro, Christensen Geir. Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats.. ESC heart failure. 2024. DOI: 10.1002/ehf2.15145.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.